BIIB Stephen A Sherwin sells $1.3M worth of shares
Mar 11, 2025, 4:30 AM
0.00%
What does BIIB do
Biogen, headquartered in Cambridge, Massachusetts, specializes in therapies for neurological diseases, employing 7,570 people and offering treatments for conditions like MS, SMA, Alzheimer's, and ALS. Their product portfolio includes TECFIDERA, SPINRAZA, and collaborations on LEQEMBI and others.
Stephen A Sherwin sold 8,760 shares of BIIB on 7 March at $150.02 per share, worth a total of $1.3M. They now own 11,318 BIIB shares, or a 44% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
